AAAAAA

   
Results: 1-4 |
Results: 4
Drug concentration effect relationship of estradiol from two matrix transdermal delivery systems: Menorest (R) and Climara (R)
Authors: Andersson, TLG Stehle, B Davidsson, B Hoglund, P
Citation: Tlg. Andersson et al., Drug concentration effect relationship of estradiol from two matrix transdermal delivery systems: Menorest (R) and Climara (R), MATURITAS, 35(3), 2000, pp. 245-252
Bioavailability of estradiol from two matrix transdermal delivery systems:Menorest (R) and Climara (R)
Authors: Andersson, TLG Stehle, B Davidsson, B Hoglund, P
Citation: Tlg. Andersson et al., Bioavailability of estradiol from two matrix transdermal delivery systems:Menorest (R) and Climara (R), MATURITAS, 34(1), 2000, pp. 57-64
A 24-month, double-blind, placebo-controlled multicentre pilot study of the efficacy and safety of nicergoline 60 mg per day in elderly hypertensive patients with leukoaraiosis
Authors: Bes, A Orgogozo, JM Poncet, M Rancurel, G Weber, M Bertholom, N Calvez, R Stehle, B
Citation: A. Bes et al., A 24-month, double-blind, placebo-controlled multicentre pilot study of the efficacy and safety of nicergoline 60 mg per day in elderly hypertensive patients with leukoaraiosis, EUR J NEUR, 6(3), 1999, pp. 313-322
17 beta-Estradiol delivered by three different matrix patches 50 mu g/day - A three way cross-over study in 21 postmenopausal women
Authors: Rohr, UD Nauert, C Stehle, B
Citation: Ud. Rohr et al., 17 beta-Estradiol delivered by three different matrix patches 50 mu g/day - A three way cross-over study in 21 postmenopausal women, MATURITAS, 33(1), 1999, pp. 45-58
Risultati: 1-4 |